• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 15-12B filed by Apria Inc.

    4/8/22 10:10:58 AM ET
    $APR
    Medical/Dental Instruments
    Health Care
    Get the next $APR alert in real time by email
    15-12B 1 d343965d1512b.htm 15-12B 15-12B

    As filed with the Securities and Exchange Commission on April 8, 2022

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 15

     

     

    CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

    UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

    OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)

    OF THE SECURITIES ACT OF 1934.

    Commission File Number: 001-40053

     

     

    Apria, Inc.

    (Exact name of registrant as specified in its charter)

     

     

    7353 Company Drive

    Indianapolis, Indiana 46237

    (800) 990-9799

    (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

     

     

    Common Stock, par value $0.01 per share

    (Title of each class of securities covered by this Form)

    None

    (Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

     

     

    Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

     

    Rule 12g-4(a)(1)    ☒
    Rule 12g-4(a)(2)    ☐
    Rule 12h-3(b)(1)(i)    ☒
    Rule 12h-3(b)(1)(ii)    ☐
    Rule 15d-6    ☐
    Rule 15d-22(b)    ☐

    Approximate number of holders of record as of the certification or notice date: 2

     

     

     


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, Apria, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

    Date: April 8, 2022

    APRIA, INC.
    By:  

    /s/ Nicholas J. Pace

      Name: Nicholas J. Pace
      Title: Director
    Get the next $APR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $APR

    DatePrice TargetRatingAnalyst
    1/11/2022$37.50Buy → Neutral
    UBS
    1/10/2022$39.00Buy
    Citigroup
    11/19/2021$39.00Buy
    Citigroup
    11/8/2021$43.00Buy
    Citigroup
    7/19/2021$32.00 → $29.00Buy → Neutral
    Goldman Sachs
    6/30/2021$33.00Buy
    Citigroup
    More analyst ratings